Sunlight–derived vitamin D affects interleukin-4 level, T helper 2 serum cytokines, in patients with Graves’ disease: a prospective cohort study

  • Dyah Purnamasari Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta
  • Pradana Soewondo Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta
  • Samsuridjal Djauzi Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta
Keywords: Graves’ disease, IFN-γ, IL-4, sunlight exposure, Th1 and Th2 pathway, vitamin D
Abstract viewed: 1311 times
PDF downloaded: 487 times

Abstract

Background: Graves’ disease (GD) is the most common autoimmune disease leading to hyperthyroidism. The role of Th1/Th2 pathways balance in GD is still controversial. Vitamin D is reported to have an effect on those pathways. This study aims to examine the effect of sunlight exposure on vitamin D 25(OH) level and Th1 and Th2 pathway-derived cytokines in GD patients.

Methods: A prospective cohort study was conducted on 32 GD patients to compare the effect of sunlight exposure on vitamin D level and cytokines of Th1 and Th2 pathways between exposed and unexposed groups. Exposed group received sunlight exposure three times a week for 30 minutes each between 9–11 a.m for 1 month. Thyroid stimulating hormone (TSH), free thyroxin (fT4), vitamin D 25(OH), interferon-γ (IFN-γ) and interleukin-4 (IL-4) serum levels, were investigated before and after one month of sunlight exposure. Paired t-test or Mann Whitney test were used to analyze the difference between exposed and unexposed GD groups before and after sun exposure.

Results: One month of sunlight exposure increased vitamin D 25(OH) level by 27.90% among exposed GD group (15.34 ng/mL to 19.62 ng/mL, p<0.001). Meanwhile, unexposed GD group’s vitamin D 25(OH) level decreased from 20.48 ng/mL to 18.86 ng/mL (p<0.001). Increased vitamin D 25(OH) level in exposed group was not accompanied by the increase of IL-4 level after sunlight exposure.

Conclusion: Sunlight exposure increases vitamin D 25(OH) serum level and may affect the level of IL-4, Th2 pathway-derived cytokine, in patients with GD. However, the role of sunlight-derived vitamin D on IFN-γ in GD patients can not be concluded in this study.

References

  1. Orgiazzi J. Thyroid autoimmunity. Presse Med. 2012;41(12P2):e611–25.

  2. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39–51. http://dx.doi.org/10.1093/bmb/ldr030

  3. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003;24(6):802–35. http://dx.doi.org/10.1210/er.2002-0020

  4. Kidd P. Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8(3):223–46.

  5. Nagayama Y, Saitoh O, Mclachlan SM, Rapoport B, Kano H, Kumazawa Y. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implication for the Th1/Th2 paradigm. Clin Exp Immunol. 2004;138(3):417–22. http://dx.doi.org/10.1111/j.1365-2249.2004.02641.x

  6. Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation. 2004;11(4):209–13. http://dx.doi.org/10.1159/000078438

  7. Wahono CS, Rusmini H, Soelistyoningsih D, Hakim R, Handono K, Endharti AT, et al. Effects of 1,25(OH)2D3 in immune response regulation of systemic lupus erithematosus (SLE) patient with hypovitamin D. Int J Clin Exp Med. 2014;7(1):22–31.

  8. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune disease? A systematic review of the literature. Autoimmun Rev. 2012;12(2):127–36. http://dx.doi.org/10.1016/j.autrev.2012.07.007

  9. Yamashita H, Noguchi S, Takatsu K, Koike E, Murakami T, Watanabe S, et al. High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J. 2001;48(1):63–9. http://dx.doi.org/10.1507/endocrj.48.63

  10. Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F, et al. Serum vitamin D levels are decreased in patients without remission of Graves' disease. Endocrine. 2013;43(1):230–2. http://dx.doi.org/10.1007/s12020-012-9789-6

  11. Setiati S, Oemardi M, Sutrisna B, Supartondo. The role of ultraviolet-B from sun exposure on vitamin D3 and parathyroid hormone level in elderly women in Indonesia. Asian J Gerontol Geriatr. 2007;2:126–32.

Published
2015-12-31
How to Cite
1.
Purnamasari D, Soewondo P, Djauzi S. Sunlight–derived vitamin D affects interleukin-4 level, T helper 2 serum cytokines, in patients with Graves’ disease: a prospective cohort study. Med J Indones [Internet]. 2015Dec.31 [cited 2019Nov.22];24(4):228-33. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/1270
Section
Clinical Research